Role of the Bronchoalveolar Lavage in Noncritically Ill Patients during the SARS-CoV-2 Epidemic
Table 1
Demographic and baseline characteristics. Typical symptoms of SARS-CoV-2 infection correspond to the presence of more than one of the following signs or symptoms: fever, cough, dyspnea, hypoxemia, or flu-like syndrome. Typical chest CT scan features of a SARS-CoV-2 infection include the presence of peripheral bilateral ground glass opacities with or without consolidations and intralobular septa thickening.
All ()
Center 1 ()
Center 2 ()
Age (y)
0.006
Male (%)
33 (60%)
20 (57%)
13 (65%)
0.775
Comorbidities (%)
Chronic pulmonary diseases
14 (25%)
8 (23%)
6 (30%)
0.751
Cardiovascular diseases
26 (47%)
18 (51%)
8 (40%)
0.575
Diabetes
8 (14%)
5 (14%)
3 (15%)
>0.999
Digestive diseases
8 (14%)
6 (17%)
2 (10%)
0.696
Kidney diseases
8 (14%)
6 (17%)
2 (10%)
0.696
Immunocompromised (%)
17 (31%)
14 (40%)
3 (15%)
0.072
Typical symptoms of SARS-CoV-2 infection (%)
31 (56%)
19 (54%)
12 (60%)
0.781
Typical SARS-CoV-2 chest CT features (%)
29 (53%)
17 (49%)
12 (60%)
0.575
Number of patients with 2 negative NP swab before BAL (%)
24 (44%)
16 (46%)
8 (40%)
0.781
Time between the symptom onset and the first NP swab ()
0.789
Time between the symptom onset and the BAL ()
>0.999
FiO2 (%, )
All
0.349
Immunocompromised
0.637
Nonimmunocompromised
0.183
Treatment at the time of the BAL (%)
Antibiotics
14 (25%)
5 (14%)
9 (45%)
0.022
Hydroxychloroquine
17 (31%)
10 (29%)
7 (35%)
0.767
Antiviral
0
0
0
NA
: difference between center 1 and center 2. Abbreviations: NP—nasopharyngeal; SD—standard deviation; y—years; BAL—bronchoalveolar lavage; NA—not applicable.
